Moreover, Beclin 2 interacts with STX5 to promote the fusion of ATG9A-mediated vesicles with autophagosomes, degrading MEKK3 and thus suppressing the development of lymphoma [43]. The gene discussed is BECN2; the disease is lymphoma.